Clinical Trials Directory

Trials / Sponsors / Mercator MedSystems, Inc.

Mercator MedSystems, Inc.

Industry · 10 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingTemsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below t
Peripheral Artery Disease, Critical Limb Ischemia
Phase 32025-07-30
RecruitingPerivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit
Iliofemoral; Thrombosis
Phase 22022-08-08
RecruitingPerivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit
Thrombosis, Deep Vein, Iliofemoral; Thrombosis
Phase 22021-10-29
TerminatedTemsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After
Peripheral Arterial Disease
Phase 22019-10-01
UnknownTemsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)
Chronic Limb Ischemia
Phase 22017-03-03
UnknownLower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherec
Chronic Limb Ischemia
Phase 22016-06-01
UnknownLower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percuta
Chronic Limb Ischemia
Phase 22016-01-01
CompletedDANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outco
Peripheral Arterial Disease
—2015-05-01
CompletedBroncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer
N/A2014-07-01
CompletedEffectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Peripheral Arterial Diseases
Phase 42013-11-01